Antidyslipidemic effect and antioxidant activity of anthraquinone derivatives from Rheum emodi rhizomes in dyslipidemic rats

Journal of Natural Medicines

Volumn 68, Issue 2, 2014, Pages 363-371

  Mishra, Sunil K ^a   Tiwari, Shashi ^b   Shrivastava, Atul ^a   Srivastava, Shishir ^a   Boudh, Goutam K ^c   Chourasia, Shivendra K ^d   Chaturvedi, Upma ^a   Mir, Snober S ^e   Saxena, Anil K ^a   Bhatia, Gitika ^b   Lakshmi, Vijai ^a,b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c A P S UNIVERSITY   (India)

^d DR H S GOUR UNIVERSITY   (India)

^e INTEGRAL UNIVERSITY   (India)

Author keywords

Antidyslipidemic activity; Antioxidant; HMG CoA reductase; Lecithin cholesterol acyl transferase activity; Post heparin lipolytic activity; Rheum emodi rhizomes

Indexed keywords

ALLOPURINOL; ALPHA TOCOPHEROL; ANTHRAQUINONE DERIVATIVE; ANTILIPEMIC AGENT; ANTIOXIDANT; CHRYSOPHANOL 8 O BEXTA DEXTRO GLUCOPYRANOSIDE; CHRYSOPHENOL; EMODIN; EMODIN 8 O BETA DEXTRO GLUCOPYRANOSIDE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN; MANNITOL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; PLANT EXTRACT; RHEUM EMODI EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TYLOXAPOL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG SCREENING; DYSLIPIDEMIA; LIPID METABOLISM; LIPID PEROXIDATION; LIPOLYSIS; MALE; NONHUMAN; RAT; RHEUM; RHEUM EMODI; RHIZOME;

ANIMALS; ANTHRAQUINONES; ANTIOXIDANTS; DYSLIPIDEMIAS; EMODIN; LIPID METABOLISM; LIPIDS; LIVER; MALE; PLANT EXTRACTS; POLYETHYLENE GLYCOLS; RATS; RHEUM; RHIZOME;

EID: 84896377164     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-013-0810-z     Document Type: Article

References (36)

1. Kannel WB, Castelli WP, Gordon T, McNamara PM (1971) Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74:1-12
2. Sparrow CP, Olszewski J (1993) Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J Lipid Res 34:1219-1228
3. Williams KJ, Tabas I (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 5:551-561
4. Drechsler M, Megens RT, Van Zandvoort M, Weber C, Soehnlein O (2010) Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122:1837-1845
5. Eisenberg DA (1998) Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials. Am J Med 104:2S-5S
6. Istvan ES, Deisenhofer J (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292:1160-1164
7. Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, Gurwitz JH, Chan KA, Goodman MJ, Platt R (2004) Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292:2585-2590
8. Barker BJ, Goodenough RR, Falko JM (2003) Fenofibrate monotherapy induced rhabdomyolysis. Diabetes Care 8:2482-2483
9. Nautiyal BP, Prakash V, Maithani UC, Chauhan RS, Purohit H, Nautiyal MC (2003) Germinability, productivity and economic viability of Rheum emodi Wall. ex Meissn. cultivated at lower altitude. Curr Sci 84:143-148
10. Kapoor LD (1990) Handbook of Ayurvedic medicinal plants. CRC, Boca Raton, pp 487-497
11. Babu KS, Srinivas PV, Praveen B, Kishore KS, Murty US, Rao JM (2003) Antimicrobial constituents from the rhizomes of Rheum emodi. Phytochemistry 62:203-207
12. Agarwal SK, Singh SS, Verma S, Kumar S (2000) Antifungal activity of anthraquinone derivatives from Rheum emodi. J Ethnopharmacol 72:43-46
13. Huang Q, Lu G, Shen HM, Chung MC, Ong CN (2007) Anti-cancer properties of anthraquinones from rhubarb. Med Res Rev 5:609-630
14. Suresh Babu K, Tiwari AK, Srinivas PV, Ali AZ, China Raju B, Rao JM (2004) Yeast and mammalian alpha-glucosidase inhibitory constituents from Himalayan rhubarb Rheum emodi Wall. ex Meisson. Bioorg Med Chem Lett 14:3841-3845
15. Li C, Ye Y (1981) Effect of rhapontin of Rheum hotaoense on lipid and lipoprotein level serum. Acta Pharm Sinica 17:699-702
16. Verma SC, Singh NP, Sinha AK (2005) Determination and locational variation in the quantity of hydroxyl anthraquinones and their glycosides in rhizomes of Rheum emodi using high-performance liquid chromatography. J Chromatogr A 1097:59-65
17. Ayyangar NR, Bapat DS, Joshi BS (1961) Anthraquinones and anthrone series: part XXVI- a new synthesis of chrysophanol, rhein, islandicin, emodin and physcion. J Sci Ind Res 20B:493-497
18. Seo EJ, Ngoc TM, Lee SM, Kim YS, Jung YS (2012) Chrysophanol-8-O- glucoside, an anthraquinone derivative in rhubarb, has antiplatelet and anticoagulant activities. J Pharmacol Sci 118:245-254
19. Xiang MX, Xu Z, Su HW, Hu J, Yan YJ (2011) Emodin-8-O-β-d-glucoside from Polygonum amplexicaule D. Don var. sinense Forb. promotes proliferation and differentiation of osteoblastic MC3T3-E1 cells. Molecules 16:728-737
20. Kumar V, Khan MM, Khanna AK, Singh R, Singh S, Chander R, Mahdi F, Mahdi AA, Saxena JK, Singh RK (2008) Hypolipidemic activity of Anthocephalus indicus (kadam) in hyperlipidemic rats. Med Chem Res 17:152-158
21. Parekh AC, Jung DH (1970) Cholesterol estimation with ferric acetate-uranium acetate and sulfuric acid, ferrous sulfate reagents. Anal Chem 42:1423-1427
22. Zilversmit DB, Davis AK (1950) Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med 35:155-160
23. Bucolo G, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482
24. Shrivastava A, Chaturvedi U, Singh SV, Saxena JK, Bhatia G (2013) Lipid lowering and antioxidant effect of miglitol in triton treated hyperlipidemic and high fat diet induced obese rats. Lipids 48:597-607
25. Sashidhara KV, Singh SP, Srivastava A, Puri A, Chhonker YS, Bhatta RS, Shah P, Siddiqi MI (2011) Discovery of a new class of HMG-CoA reductase inhibitor from Polyalthia longifolia as potential lipid lowering agent. Eur J Med Chem 46:5206-5211
26. Nagasaki T, Akanuma Y (1977) A new colorimetric method for determination of plasma lecithin-cholesterol acyltransferase activity. Clin Chem Acta 75:371-375
27. Wing DR, Robinson DS (1968) Clearing factor lipase in adepose tissue. Biochem J 109:841-849
28. Mays PA, Felts JM (1968) The functional status of lipoprotein lipase in rat liver. Biochem J 108:483-487
29. Prasad J, Shrivastava A, Khanna AK, Bhatia G, Awasthi SK, Narender T (2012) Antidyslipidemic and antioxidant activity of the constituents isolated from the leaves of Calophyllum inophyllum. Phytomedicine 19:1245-1249
30. Rader DJ, Fitzgerald GA (1998) State of the art: atherosclerosis in a limited edition. Nat Med 4:899-900
31. Wattanapitayakul SK, Bauer JA (2001) Oxidative pathways in cardiovascular disease: roles, mechanisms and therapeutic implications. Pharmacol Therapeut 89:187-206
32. Sashidhara KV, Kumar M, Sonkar R, Singh BS, Khanna AK, Bhatia G (2012) Indole-based fibrates as potential hypolipidemic and antiobesity agents. J Med Chem 55:2769-2779
33. Schotz MC, Seanu A, Page IH (1957) Effect of triton on lipoprotein lipase of rat plasma. Am J Physiol 188:399-402
34. Applebaum DM, Goldberg AP, Pykalisto OJ, Brunzell JD, Hazzard WR (1977) Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase. J Clin Invest 59:60-608
35. Jain KS, Kathiravan MK, Somania RS, Shishooc CJ (2007) The biology and chemistry of hyperlipidemia. Bioorg Med Chem 15:4674-4699
36. Tzeng TF, Lu HJ, Liou SS, Chang CJ, Liu IM (2012) Emodin, a naturally occurring anthraquinone derivative, ameliorates dyslipidemia by activating AMP-activated protein kinase in high-fat-diet-fed rats. Evid Based Complement Alternat Med 2012:781812. doi: 10.1155/2012/781812